Latest Financials News

Alexium International Group has boosted sales to $1.03 million following its Microtek Laboratories acquisition, shifting focus to manufacturing-led growth and expanding its flame-retardant and thermal regulation product lines.

Regis Healthcare expects FY26 underlying EBITDA of approximately $135 million, buoyed by near-record occupancy and a disciplined capital strategy amid evolving government reforms.

Artrya has fully integrated its Salix platform at Tanner Health, is preparing two more US sites for launch, and is finalising FDA submission for its Coronary Flow module, backed by a strong cash position of $76.6 million.

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Delorean Corporation reported solid progress in Q3 FY2026, including a positive Final Investment Decision for its NSW1 Horsley Park bioenergy facility backed by $30.5 million in grants, alongside ongoing construction at its flagship SA1 Salisbury project.

Dimerix has completed adult patient recruitment in its Phase 3 ACTION3 trial for DMX-200, with a blinded review confirming the study remains statistically powered to demonstrate treatment efficacy. The company also appointed a new CFO and is negotiating up to US$50 million in non-dilutive funding.

Electro Optic Systems (ASX: EOS) reported a 13% increase in contract backlog to A$518 million in Q1 2026, driven by multiple major defence orders and the opening of a new Singapore facility. The company’s cash position remains strong despite a $4 million ASIC penalty.

Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.

Fin Resources has secured full ownership of the Cabin Lake Gold Project and delivered promising high-grade gold intercepts in maiden drilling, supported by integrated geophysical surveys. The company raised A$3.75 million to fund ongoing exploration and announced key board changes.

Blackstone Minerals has cleared a key regulatory hurdle at its Mankayan Copper-Gold Project, lifting a Cease and Desist Order and initiating a Pre-Feasibility Study. The company also strengthened its board with mining veteran Mark Williams and reported a solid cash position of $14.6 million.

Ioneer Ltd has raised US$50 million to push forward its fully permitted Rhyolite Ridge lithium-boron project in Nevada, buoyed by a federal court ruling upholding project approvals and ongoing strategic partner discussions.

Liontown Limited delivered its strongest financial quarter since production began, achieving a self-funded quarter with a $33 million cash boost and surpassing underground mining targets ahead of schedule, while maintaining FY2026 guidance amid robust lithium market conditions.